Xin Zhang
Director/Board Member chez DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Profil
Xin Zhang currently works at Dizal (Jiangsu) Pharmaceutical Co., Ltd., as Independent Director from 2020, Dizal Pharma, as Director, and WellJoint (Shanghai) Technology Co., Ltd., as Independent Director from 2019.
Ms. Zhang received her graduate degree from Tongji University.
Postes actifs de Xin Zhang
Sociétés | Poste | Début |
---|---|---|
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Director/Board Member | 08/09/2020 |
WellJoint (Shanghai) Technology Co., Ltd.
WellJoint (Shanghai) Technology Co., Ltd. Information Technology ServicesTechnology Services WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 01/11/2019 |
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Director/Board Member | - |
Formation de Xin Zhang
Tongji University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Commercial Services |
Entreprise privées | 2 |
---|---|
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Health Technology |
WellJoint (Shanghai) Technology Co., Ltd.
WellJoint (Shanghai) Technology Co., Ltd. Information Technology ServicesTechnology Services WellJoint (Shanghai) Technology Co., Ltd. engages in the research and development of information technology. It operates through the following segments: Cloud Contact Center Platform Development and Services; Intelligent Voice Analysis System Development and Services; and System Integration Service. The Cloud Contact Center Platform Development and Services segment develops Wellcloud platform as a service platform and software as a service applications to provide cloud contact center system deployment, management and services. The Intelligent Voice Analysis System Development and Services segment offers dialog analysis systems and intelligent application systems. The System Integration Services segment covers contact center local deployment solutions, and system integration solutions related to information construction. The company was founded on April 21, 2011 and is headquartered in Shanghai, China. | Technology Services |